Cellect Biotechnology Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Cellect Biotechnology Ltd., a foreign private issuer based in Kfar Saba, Israel, for the month of January 2017. The filing incorporates by reference a press release dated January 12, 2017, regarding intellectual property developments.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory milestone rather than financial performance.
Material Changes
The material change reported is the receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO). This notice protects the company's technology in multiple key indications, representing a significant advancement in its intellectual property portfolio.
Guidance, Outlook, and Risks
The filing does not contain specific financial guidance, management commentary on future earnings, or a discussion of risks and contingencies beyond the context of the patent allowance. No unusual items were reported.
Investor Verification Points
- Verify the specific scope of the "multiple key indications" covered by the USPTO Notice of Allowance.
- Confirm the status of the patent application and any remaining requirements for final issuance.
- Review the company's broader pipeline to understand how this patent supports future commercialization efforts.